JP2009525286A5 - - Google Patents

Download PDF

Info

Publication number
JP2009525286A5
JP2009525286A5 JP2008552621A JP2008552621A JP2009525286A5 JP 2009525286 A5 JP2009525286 A5 JP 2009525286A5 JP 2008552621 A JP2008552621 A JP 2008552621A JP 2008552621 A JP2008552621 A JP 2008552621A JP 2009525286 A5 JP2009525286 A5 JP 2009525286A5
Authority
JP
Japan
Prior art keywords
immunoglobulin
igm
resin
supernatant
precipitate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008552621A
Other languages
English (en)
Japanese (ja)
Other versions
JP5697847B2 (ja
JP2009525286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/061269 external-priority patent/WO2007106617A2/en
Publication of JP2009525286A publication Critical patent/JP2009525286A/ja
Publication of JP2009525286A5 publication Critical patent/JP2009525286A5/ja
Application granted granted Critical
Publication of JP5697847B2 publication Critical patent/JP5697847B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008552621A 2006-01-30 2007-01-30 IgMを使用する治療方法および予防方法 Active JP5697847B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76342206P 2006-01-30 2006-01-30
US60/763,422 2006-01-30
PCT/US2007/061269 WO2007106617A2 (en) 2006-01-30 2007-01-30 Method of treatment and prophylaxis of diseases related to amyloid deposition using igm

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013179382A Division JP2013256529A (ja) 2006-01-30 2013-08-30 IgMを使用する治療方法および予防方法

Publications (3)

Publication Number Publication Date
JP2009525286A JP2009525286A (ja) 2009-07-09
JP2009525286A5 true JP2009525286A5 (enExample) 2010-03-18
JP5697847B2 JP5697847B2 (ja) 2015-04-08

Family

ID=38510126

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008552621A Active JP5697847B2 (ja) 2006-01-30 2007-01-30 IgMを使用する治療方法および予防方法
JP2013179382A Pending JP2013256529A (ja) 2006-01-30 2013-08-30 IgMを使用する治療方法および予防方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013179382A Pending JP2013256529A (ja) 2006-01-30 2013-08-30 IgMを使用する治療方法および予防方法

Country Status (7)

Country Link
US (1) US8852585B2 (enExample)
EP (1) EP1981540B1 (enExample)
JP (2) JP5697847B2 (enExample)
ES (1) ES2409844T3 (enExample)
PL (1) PL1981540T3 (enExample)
PT (1) PT1981540E (enExample)
WO (1) WO2007106617A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
SG10201706600VA (en) 2005-11-30 2017-09-28 Abbvie Inc Monoclonal antibodies and uses thereof
KR20080090408A (ko) 2005-11-30 2008-10-08 아보트 러보러터리즈 항-Aβ 글로불로머 항체, 이의 항원-결합 잔기, 상응하는하이브리도마, 핵산, 벡터, 숙주 세포, 당해 항체의 제조방법, 당해 항체를 포함하는 조성물, 당해 항체의 용도 및당해 항체의 사용 방법
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
CA2701793C (en) 2007-10-05 2017-04-25 Genentech, Inc. Use of anti-amyloid beta antibody in ocular diseases
EP2558494B1 (en) 2010-04-15 2018-05-23 AbbVie Inc. Amyloid-beta binding proteins
CN103179981B (zh) 2010-07-30 2017-02-08 Ac免疫有限公司 安全和功能性的人源化抗β‑淀粉样蛋白抗体
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
DK2961426T3 (da) * 2013-02-26 2019-12-02 Baxalta GmbH Behandling af sygdomme i centralnervesystemet ved intranasal indgivelse af immunoglobulin g
AU2014262890B2 (en) * 2013-05-06 2019-01-31 Takeda Pharmaceutical Company Limited Treatment of Alzheimer's disease subpopulations with pooled immunoglobulin G
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
TW202216735A (zh) * 2020-07-10 2022-05-01 愛爾蘭商格里佛全球營運有限公司 製備包含人血漿來源的免疫球蛋白m之組合物的方法及儲存穩定的液體組合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927112C1 (enExample) 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
US5554601A (en) 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US5877399A (en) 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
US7473423B2 (en) * 1994-04-29 2009-01-06 Mayo Foundation For Medical Education And Research Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
US5986054A (en) 1995-04-28 1999-11-16 The Hospital For Sick Children, Hsc Research And Development Limited Partnership Genetic sequences and proteins related to alzheimer's disease
JP2000506375A (ja) 1996-01-26 2000-05-30 エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ アルツハイマー病に関連する核酸およびタンパク質、ならびにその使用
EP0835880A1 (de) 1996-10-14 1998-04-15 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
EP1172378A1 (en) 2000-07-12 2002-01-16 Richard Dr. Dodel Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
FR2824568B1 (fr) 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
WO2003097093A1 (en) * 2002-05-15 2003-11-27 Rauno Joks METHOD OF TREATING IMMUNE-MEDIATED DISEASES BY ADMINISTRATION OF IgM
EP1652925B1 (en) * 2003-07-15 2010-12-08 Chugai Seiyaku Kabushiki Kaisha IgM PRODUCTION BY TRANSFORMED CELLS AND METHODS FOR QUANTIFYING SAID IgM PRODUCTION

Similar Documents

Publication Publication Date Title
JP2009525286A5 (enExample)
JP4776615B2 (ja) 抗体精製
US10053489B2 (en) Method for purifying antibody
Murphy et al. Technology advancements in antibody purification
ES2449148T3 (es) Purificación de inmunoglobulinas
EP0143413B1 (de) Digitalis-Antikörper, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von Digitalis-Intoxikationen
JP2016519137A5 (enExample)
Hage et al. Affinity chromatography: a historical perspective
CL2014001334A1 (es) Una proteina de union, anticuerpos o fragmentos del mismo que se une a her-3; molecula de acido nucleico que la codifica; procedimiento de produccion; composicion farmaceutica que lo comprende ; su uso para tratar enfermedades asociadas a her -3; y metodo de diagnostico de una enfermedad (div. sol. 3748-2006).
JP2016530533A5 (enExample)
CN116731129A (zh) 修饰的κ轻链-结合多肽
JP2019034963A (ja) 陽イオン交換基を用いた新規抗体精製法(Novel Antibody Purification method using Cation Exchanger)
JP5947802B2 (ja) ミックスモードクロマトグラフィーによる抗体捕捉の最適化方法
JP2018033454A5 (enExample)
JP2007532477A5 (enExample)
Bolton et al. Inactivation of viruses using novel protein A wash buffers
Holstein et al. Mobile phase modifier effects in multimodal cation exchange chromatography
JP6335785B2 (ja) ミックスモード抗体アフィニティー分離マトリックスとそれを用いた精製方法および標的分子
JP2011521653A5 (enExample)
US6613884B1 (en) Method for the removal/purification of serum albumins and means for use in the method
Al Musaimi et al. Advances in therapeutic peptides separation and purification
CN104507954A (zh) 磨光白蛋白的方法
BRPI0708451A2 (pt) adsorventes para purificação de proteìnas
Zhang et al. Binary adsorption processes of albumin and immunoglobulin on hydrophobic charge-induction resins
Zhang et al. Purification of monoclonal antibodies by chemical affinity mixed mode chromatography